US 11,926,601 B1
الصحة - Health
2024
مكتب البراءات الأمريكي - US Patent Office
Ahmed; Hany Mohamed Abd El-Lateef (Al-Ahsa, SA), Ali; Mai Mostafa Khalaf (Al-Ahsa, SA), Amer; Amer A. (Al-Ahsa, SA), Ahmed; Antar Ahmed Abdelhamid (Al-Ahsa, SA) Applicant: KING FAISAL UNIVERSITY (Al-Ahsa, SA)
A 5-spiro 9,10-dihydroanthracene derivative of imidazolidine-2,4-dione compound, its synthesis, and its use as an anticancer agent.